BACKGROUND AND PURPOSE: In preclinical stroke models, high-dose human albumin confers robust neuroprotection. We investigated the safety and tolerability of this therapy in patients with acute ischemic stroke.
英
美
- 背景及目的：在臨床前的動(dòng)物中風(fēng)模型中，高劑量的人血清白蛋白顯示出明顯的神經(jīng)保護作用。本文研究了人血清白蛋白治療急性缺血性中風(fēng)的耐受性及安全性。
